The Protective or Curative Element in Type B H. influenzae Rabbit Serum * by Alexander, Hattie E. et al.
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GRACE LEIDY
The value of a quantitative approach to serum therapy of type b
H. influenzae meningitis has been established by the experience of a
number of institutions. It is recognized that whereas some patients
respond promptly following the administration of 50 mg. of spe-
cific type b H. influenzae antibody nitrogen others need several
hundred milligrams before recovery from infection is complete.
The requirements for efficient application of the quantitative
approach have been described.' They can be met by three steps:
1. Accurate standardization of serum: A quantitative chemical
method which determines milligrams of agglutinin or anti-poly-
saccharide nitrogen per ml. has been used.3 Either measure seems
suitable, since the anticarbohydrate usually varies from about 70 to
100 per cent of the total agglutinin nitrogen.
2. Appraisal of severity of infection: As a guide to the number
of milligrams of antibody nitrogen needed initially for a given
patient, the concentration of dextrose in the cerebrospinal fluid has
been recommended.2 It is aimed to administer at one time a dose
deemed sufficient for recovery.
3. Criteria for sufficiency of dose adnxm'stered: Both of the
methods recommended, the capacity of the patient's serum to pro-
duce capsular swelling when diluted 1:10, and the immediate wheal
reaction to the intracutanreous injection of the specific carbohydrate,6
establish the presence of an excess of anticarbohydrate.
It is apparent that the validity of these measures as guides is
dependent upon a premise which at first was assumed to be true;
ilamely, that the protective or curative element of therapeutic type-
specific rabbit H. influenzae antiserum is the anticarbohydrate anti-
body. Subsequently, Seidman, Dingle, and Fothergill" published
a summary of investigations which also led to this conclusion.
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The present report presents the results of experiments designed
to determine whether or not the protective or curative fraction is
actually anticarbohydrate. Samples of type b H. influenzae antisera
were absorbed with specific polysaccharide preparations isolated
from broth cultures of type b H. influenzae by three different meth-
ods. Mouse protection tests were performed to assess the power of
each unabsorbed and the corresponding absorbed serum to immunize
passively mice against lethal type b H. influenzae infections. Table
1 lists the samples of sera used in these experiments, and the anti-
TABLE 1
QUANTITATIVE DATA ON THE SERA USED IN THE EXPERIMENTS REPORTED
Antibody nitrogen
content of
unabsorbedserum, mg. Polysaccharide Absorbed serum,
Seru2m lot used for agglutinin N
lot Agglutinin Precipitin absorption in mg.
Serum A 1.1 0.84 1* 0.14 (A1)
1.1 0.84 1 0.14 (A1)
Serum B 1.07 1.06 1 0.08 (B1)
Serum A 1.1 0.84 2** 0.1+ (A2)
1.1 0.84 2 0.06 (As)
Serum A 1.1 0.79 3*** 0 (A4)
Serum C 1.62 3 0.01 (C1)
Serum D 1.96 1.87 3 0.03 (D1)
Serum E 0.65 0.36 3 ..... (E1)
* Lot I - Impure polysaccharide.
** Lot 2 -Trpsinized Lot 1.
** Lot 3 - Purified protein-free polysaccharide.
body nitrogen content of each before and after absorption with the
polysaccharide preparation indicated.
Materials and methods
Determination ot agglutinin nitrogen: Details of the method have been
given elsewhere.' Accurately measured volumes of formalinized, washed
H. influenzae type b suspension (grown as described under the mouse pro-
tection tests, but treated with 0.5 per cent formalin at a far greater cell
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density) were added, in duplicate to accurately measured quantities of neutral-
ized diluted serum and mixed. After appropriate standing and washing in
the cold, the difference between the nitrogen content (micro-Kjeldahl) of
the agglutinated suspension and that of a control suspension without antiserum
was taken as agglutinin N. Any additional agglutinin N found in the
supernatant antiserum on repetition of the process was added.
Preparation of specific polysaccharide of H. influenzae type b: A prepara-
tion was made from 6.5 liters of Levinthal broth culture,3 but as the product
was less active weight for weight, and therefore presumably less pure, than
that of Dingle and Fothergill5 details are not given. The polysaccharide
designated Lot 1 was used in the protection tests summarized in Tables 2
and 3, but as a 1 per cent solution gave a weak biuret test tryptic digestion
was resorted to in order to remove any trypsin-labile protein antigen which
might have been present. For this purpose 500 mg. of Fairchild's trypsin
were suspended in 25 ml. of cold water, allowed to stand in the cold for
about an hour, and centrifuged. The supernatant solution was treated in
the cold with normal acetic acid to maximum precipitation and centrifuged.
Ten ml. of the active supernatant solution (now 35 ml.) were added to a
solution of 90 mg. of the crude specific polysaccharide in 5.5 ml. The solu-
tion was neutralized to phenol red and allowed to stand at 370 C. in the
presence of toluene for about 1 week. The solution was acidified with acetic
acid, shaken with chloroform and butyl alcohol"2 until no middle layer
formed, and isolated by precipitation with alcohol in the presence of sodium
acetate. In the biuret test a 0.5 per cent solution gave a grayish precipitate
which turned violet on heating and is therefore probably to be considered
positive. Possibly some of the protein, if any was present, was derived from
the 150 mg. aliquot of trypsin used. On the basis of ash-free weight, the
product was very nearly as active a precipitant of anti-H. influenzae rabbit
sera as the best of those mentioned in the previous.paper.3 As shown in
Table 3, like the undigested material, the trypsin-treated product (Polysac-
charide Lot 2) removed practically all of the antibody from the antiserum
used. Precipitin estimations were run according to a technic described by
Alexander and Heidelberger3 and in earlier papers. Lot 3 polysaccharide8
was protein-free and appeared to be relatively pure and undegraded.
Absorption of antisera: A given volume of serum was precipitated with
the quantity of type b specific polysaccharide calculated from previous analyses
on accurately measured analytical samples as necessary to precipitate the anti-
carbohydrate. After 2 days or more in the cold the mixtures were centri-
fuged and the clear supernatant liquid was used in the tests. Aliquot portions
were analyzed for agglutinin nitrogen in order to check the completeness of
anticarbohydrate removal, since measurement of the relatively large quan-
tities required for the animal tests had been made in uncalibrated, sterile
pipettes. The results of the analyses are given in Table 1.
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Mouse protection tests: The organisms were suspended in mucin in order
to render them lethal in small numbers in control animals, thus eliminating
the toxic factor. Miller first used this method of enhancement of virulence
in mouse tests with meningococcus.10 Fothergill and Dingle7 applied the
principle to testing the virulence of H. influenzae.
Culture: Cultures grown from the spinal fluid withdrawn before treat-
ment were dried and sealed under vacuum by a method devised by Brown.4
Organisms so preserved show no significant loss of virulence for an indefinite
period of years. In preparation for each test a new specimen of dried culture
was planted in Levinthal broth9 within 48 hours of beginning the test. A
Levinthal agar plate was seeded with 0.3 ml. of an 18-hour Levinthal broth
culture, and after incubation for 5Y2 to 6 hours the growth was washed off
with plain nutrient broth and the density was adjusted to 3.5 cm. by the
Gates turbidometer. Using the latter suspension as the standard, dilutions
were made with mucin in multiples of 10 from 10-1 to 10-7 in the early
experiments and to 10- thereafter; in all cases the dose of organisms indi-
cated in the experiments was contained in 1 ml. This was introduced into
the peritoneal cavity within 1 hour following the injection of the serum.
The minimal number of organisms causing death in at least 50 per cent of
the mice, that is, the M.L.D., was determined for all cultures each time
they were used in testing a protective agent. This number varied between
200 to 2000 organisms when mucin, lot No. 43457, was used in the first 5
experiments to be reported. In all 4 of the subsequent experiments 20 or
fewer organisms were suflicient to kill 50 per cent of the control mice inocu-
lated. A new lot of mucin, No. 51556, was used in these experiments.
Mucin: Seven grams of finely powdered mucin (lots No. 43457 and
No. 51556, type 1701W-Wilson Laboratories) were dissolved in 100 ml.
of distilled water by grinding in a mortar with pestle, the water being added
to the powder in small amounts after intervals of grinding to obtain a smooth
paste. The suspension was sterilized by autoclaving at 10 lbs. for 15 minutes.
Large particles were removed by centrifuging for 5 minutes at the slowest
centrifuge speed. The supernatant fluid was then adjusted to pH 7.2 with
normal sodium hydroxide and 1 per cent of dextrose was added.
Mice: White Swiss male mice were used throughout all experiments.
Except when indicated otherwise, the weight range was from 13 to 15 gm.
All mice were weighed on the day of the test.
Experimental results
Table 2 presents the results of duplicate experiments compar-
ing the protective power of serum A before and after precipita-
tion with an impure type b polysaccharide (Lot 1). It is seen in
the first experiment that this.serum, which contained 1.1 mg. of
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type b H. influenzae antibody nitrogen per ml. when measured as
agglutinin and 0.84 mg. of precipitin nitrogen, protected, when
diluted 1:300, 7 out of 10 mice against 1000 M.L.D. Therefore,
0.0022 mg. of antibody nitrogen per mouse or the amount in 0.6 ml.
TABLE 2
DUPLICATE TESTS COMPARING THE PROTECTIVE POWER OF SERUM A BEFORE AND
AFTER PRECIPITATION WITH POLYSACCHARIDE LOT 1
Dose of Fateofmice at Fate ofmice at
agglutinin 104 M.L.D. of 103 M.L.D. of
Ngiven H. influenzae H. injluenzae
Serum used Dilution Y D S D S
A 1:10 66 1 9
(unabsorbed)* 1:150 4.4 0 10
1:300 2.2 3 7
A1 1:10 8.4 6 4
(absorbed)* 1:150 0.56 10 0
1:300 0.28 9 1
Controls: I0-5: 4 D, 1 S; 106: 3 D, 2 S; 10-7: 0 D, 5 S.
Count of standard: 1,500,000,000 per ml.
Repetition on A 1:150 4.4 1 9
(unabsorbed) 1:300 2.2 3 7 1 9
RepetitiononA, 1:10 8.4 10 0 5 5
(absorbed) 1:150 0.56 10 0
Controls: 104:5 D,OS; 10-:5 D,OS; 106:4 D, 1 S; 10-7:4 D, I S.
Count of standard: 900,000,000 per ml.
* Unabsorbed serum A: agglutinin N, 1.1 mg. per ml.; precipitin N, 0.84 mg.
per ml. After precipitation with specific polysaccharide (absorbed serum) A1:
agglutinin N, 0.14 mg. per ml.
D = deaths. S = survivals.
of 1:300 dilution was protective against 1000 M.L.D., the highest
infecting dose used. Following absorption with type b polysaccha-
ride, 0.14 mg. per ml. of agglutinin nitrogen remained. If all of
this antibody had possessed protective power, the 1:10 dilution
should have protected as well as did the 1:150 dilution of the origi-
nal unabsorbed serum, since the antibody content per ml. was four
times that quantity which in the' unabsorbed serum was sufficient
to protect against 1000 M.L.D. Only 4 of the 10 mice receiving
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the latter dose survived, but 6 of the 10 receiving 100 M.L.D. were
protected. In the duplicate experiment in which the M.L.D. of
the controls was 200 organisms, 0.0022 mg. of antibody nitrogen
in the unabsorbed serum protected 7 of 10 mice against 10,000
M.L.D. Four times this amount of agglutinin nitrogen in the
absorbed serum failed to protect mice against this dose. However,
50 per cent of the mice receiving 1000 M.L.D. survived. These
results suggest that while absorption of anticarbohydrate antibody
was incomplete, the remaining antibody was composed of both speci-
fic and non-specific antibody.
In Table 3 are recorded the results of the next experiment com-
paring the protective power of a different sample of serum before
and after absorption with polysaccharide preparation Lot 1. The
agglutinin and precipitin nitrogen values on this serum indicated
that virtually 100 per cent of the antibody content was type specific.
Only 0.08 mg. per ml. of agglutinin nitrogen remained after absorp-
tion. Inthis experiment the contrast between the protection afforded
by the absorbed and unabsorbed serum is more striking. Whereas
0.0021 mg. of antibody nitrogen in the unabsorbed serum protected
TABLE 3
COMPARISON OF THE PROTECTIVE VALUE OF SERUM B BEFORE AND AFTER
PRECIPITATION WITH POLYSAOCHARIDE LOT 1
Dose of Fate of mice at Fate of mice at
agglutinin 104 M.L.D. of 10s M.L.D. of
N given Ii. influenzae H. influerzzae
Serum used Dilution v D S D S
B 1:150 4.2 5t 5
(unabsorbed)* 1:300 2.1 6 4 1 9
Squibbs
B1 1:10 4.8 10 0 10 0
(absorbed)* 1:150 .32 10 0
Controls: 10-5: 5 D, 0 S; 106: 5 D, 0 S; 10-7:4 D, 1 S.
Count of standard: 1,500,000,000 per ml.
* Unabsorbed serum B: agglutinin N, 1.07 mg. per ml.; precipitin N, 1.06 mg.
per ml. Absorbed serum B1 (after precipitation with specific polysaccharide):
agglutinin N, 0.08 mg. per ml.
D = deaths. S = survivals.
t 1 mouse died within 1 hour of inoculation.
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9 of 10 mice against 1000 M.L.D., there were no survivals among
the mice receiving 0.0048 mg. of antibody nitrogen in absorbed
serum.
Since the polysaccharide preparation used in these experiments
showed a positive biuret test, it was considered advisable to free it
if possible of all traces of protein which might be present and there-
fore could absorb antiprotein antibodyWhich might possess protective
value. The polysaccharide preparation was therefore subjected to
the action of trypsin as described. Table 4 records the results of
2 protection tests which compare the curative action of serum A
before and after absorption with the trypsinized antigen. Two por-
tions of this serum were absorbed; the product used in the first
experiment of Table 4 contained 0.1+ mg. of agglutinin nitrogen
TABLE 4
SUCCESSIVE PROTECTION TESTS ON UNABSORBED SERUM A AND DIFFERENT LOTS
OF TRYPSINIZED CARBOHYDRATE-PRECIPITATED SERA
Dose of Fateof mice at Fate of mice at
agglutinin 103 M.L.D. of 10' M.L.D. of
N given H. influenzae H. inftuenzae
Serum used Dilution Y D S D S
A 1:150 4.4 3 7
(unabsorbed)* 1:300 2.2 0 10 0 10
A2 1:10 6.0 5 5 0 10
(absorbed)* 1:150 0.4 7 3
Controls: 104: 5 D, 0 S; 10-: 5 D, 0 S; 10-: 3 D, 2 S; 10-7: 1 D, 4 S.
Count of standard: 1,570,000 per ml.
Repetition on A 1:150 4.4 5 5
(unabsorbed) 1:300 2.2 6 4 3 7
A3 1:10 3.6 10 0 5 5
(absorbed)* 1:150 0.24 10 0
Controls: 104: 5 D, 0 S; 10-: 5 D, 0 S; 10-: 3 D, 2 S; 10-7: 2 D, 3 S.
Count of standard: Not successful.
*Unabsorbed serum: agglutinin N, 1.1 mg. per ml.; precipitin N, 0.84 mg.
per ml. After precipitation with specific. polysaccharide (absorbed serum A2):
agglutinin N, 0.1+ mg. per ml.; (absorbed serum A,): agglutinin N, 0.06 mg.
per ml.
D = deaths. S = survivals.
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perml. and that used in the second contained only 0.06 mg. per ml.,
since absorption was slightly more complete.
In all of the above experiments the difference in protective
power ofthe serum before and after removal of the anticarbohydrate
antibody was shown to be significant. In the experiments in which
this antibody was completely removed the serum possessed virtually
no protective power. These results indicated therefore that the
anticarbohydrate antibody was the protective or curative element in
type b H. influenzae rabbit serum. The validity of this statement
is dependent upon the purity of the polysaccharide used for absorp-
tion. Even the trypsinized polysaccharide exhibited a faintly posi-
tive biuret test. For this reason further purification of another
polysaccharide preparation was attempted. This product, Lot 3,
showed a negative biuret test and all of its properties suggested a
higher degree of purity.8 It was used as the precipitating agent for
removing the antibody from four different samples of sera, A, C,
D, and E.*
In Table 5 are summarized the results of mouse protective tests
when these sera were used as protective agents before and after
absorption with preparation 3. It is seen that, whereas very small
quantities of all four of the unabsorbed sera protected at least 50 per
cent of the mice against 10,000 M.L.D., there was virtually no
protection when the antibody was removed by precipitation with the
specific polysaccharide.
Conclusion
It is clear from the evidence presented that removal of the anti-
carbohydrate antibody from a type b H. influenzae rabbit serum
abolishes its protective power. It may be concluded therefore that
the protective or curative element in therapeutic serum is the anti-
carbohydrate antibody. The validity of the methods for application
of the quantitative approach is therefore established.
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